Cargando…
Effect of a High Protein, Low Glycemic Index Dietary Intervention on Metabolic Dysfunction-Associated Fatty Liver Disease: A Randomized Controlled Trial
BACKGROUND: Metabolic dysfunction-associated fatty liver disease (MAFLD) affects people at an increasingly younger age. The primary treatment for patients with MAFLD is diet-induced weight loss; however, excessive dieting is poorly effective. OBJECTIVES: The aim of this trial was to evaluate whether...
Autores principales: | Sun, Ping, Huang, Liping, Shuai, Ping, Wan, Zhengwei, Liu, Yingying, Xue, Jianqiang, Liu, Yuping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097015/ https://www.ncbi.nlm.nih.gov/pubmed/35571881 http://dx.doi.org/10.3389/fnut.2022.863834 |
Ejemplares similares
-
Dietary glycemic index, glycemic load, and renal cancer risk: findings from prostate, lung, colorectal, and ovarian cancer trial
por: Qi, Honggang, et al.
Publicado: (2023) -
Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults
por: Zhang, Zhongmian, et al.
Publicado: (2023) -
Effects of Dietary Nutrients on Fatty Liver Disease Associated With Metabolic Dysfunction (MAFLD): Based on the Intestinal-Hepatic Axis
por: Yao, Nan, et al.
Publicado: (2022) -
Dietary Interventions in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Houttu, Veera, et al.
Publicado: (2021) -
Mediterranean diet affects the metabolic outcome of metabolic dysfunction-associated fatty liver disease
por: Xiao, Yuji, et al.
Publicado: (2023)